Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants

Anticoagulation for cancer-associated venous thromboembolism (VTE) can be challenging due to complications—including bleeding and potential drug–drug interactions with chemotherapy—associated with vitamin K antagonists and inconvenience of low-molecular-weight heparin (LMWH). Direct oral anticoagula...

Descripción completa

Detalles Bibliográficos
Autores principales: Ay, C, Beyer-Westendorf, J, Pabinger, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594460/
https://www.ncbi.nlm.nih.gov/pubmed/30918939
http://dx.doi.org/10.1093/annonc/mdz111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594460/
https://www.ncbi.nlm.nih.gov/pubmed/30918939
http://dx.doi.org/10.1093/annonc/mdz111

Ejemplares similares